U.S. Healthcare Services Stock News

Delek US Holdings (DK) is back in focus after welcoming a decision by President Trump and the U.S. Environmental Protection Agency to grant Small Refinery Exemptions for the 2025 compliance year. The policy support arrives at a time when Delek US Holdings’ share price has moved strongly, with a 90 day share price return of 55.45% and a year to date share price return of 146.27%. The 5 year total shareholder return of 414.45% points to strong longer term momentum. Compare Delek US Holdings'...

Trupanion stock reaction and recent performance Trupanion (TRUP) has drawn fresh attention after a recent share price move, with the stock closing at $27.88 on 27 August 2026. The move comes alongside contrasting short and longer term return patterns. Over the past day the stock declined 4.36%, and over the past week it fell 12.44%. That shorter term weakness sits against a gain of 13.84% over the past month and a 29.92% rise over the past 3 months, while the 1 year return is down 38.32%. For...

Verisk Analytics (VRSK) drew fresh attention after releasing its 2026 Global Modeled Catastrophe Losses Report, which estimates insurers should brace for about $171b in annual insured catastrophe losses worldwide, the highest figure Verisk has published. Verisk Analytics has seen mixed momentum around this report, with the share price up 3.11% over the past week and 8.98% over the past 90 days, while the year to date share price return is down 12.07% and the 1 year total shareholder return is...

In August 2026, Insmed announced that Japan's Ministry of Health, Labour and Welfare approved BRINSUPRI (brensocatib 25-mg tablets) as the first and only treatment for non-cystic fibrosis bronchiectasis in adults and adolescents aged 12 and older. This third major regulatory clearance, following the U.S. and Europe, effectively establishes BRINSUPRI as a globally approved, first-in-class option for managing this chronic lung disease. We’ll now examine how Japan’s approval of BRINSUPRI as...

Trip.com Group recently reported that total travel booking GMV has risen by almost 40%, with active travel or ‘sportcation’ bookings showing strong double-digit growth across markets such as Thailand, China, Australia, New Zealand, and Malaysia. This surge in demand for experience-led, sport-focused trips highlights how travelers are prioritizing activity-rich itineraries, potentially reinforcing Trip.com Group’s push toward higher engagement and more specialized travel offerings. We’ll now...

Martin Marietta Materials stock has delivered a solid 40.8% total return over the past 5 years, yet current checks point to a company that looks fairly valued on intrinsic grounds while screening expensive on market multiples. Recent share price weakness and a low overall value score leave investors weighing how much optimism is already in the current price. Over the past 5 years, Martin Marietta Materials has returned 40.8%, which suggests long term holders have been rewarded despite more...

Why International Flavors & Fragrances Is Back On Investor Radars International Flavors & Fragrances (IFF) has drawn fresh attention after recent share price gains over the past month and past 3 months, prompting investors to reassess how its fundamentals line up with the current valuation. Set against a 12 month total shareholder return of 32.01%, the recent 8.28% 1 month share price return and 16.61% 3 month share price return suggest momentum in International Flavors & Fragrances is...

Ardelyx (ARDX) has come under closer investor scrutiny after recent share price pressure, with the stock down about 24% over the past month and roughly 31% over the past 3 months. At a latest share price of US$3.76, Ardelyx has moved sharply lower in recent months, with the 30 day share price return down 24% and the year to date share price return down 38.9%, while the 5 year total shareholder return remains positive at 168.6%. Broaden your watchlist beyond Ardelyx by scanning hand picked...

Broadcom (AVGO) just launched VMware Private AI Cloud and VMware AI Factory, giving enterprises tools to run AI models and autonomous agents alongside existing workloads on private infrastructure that is tied directly to their own data. Despite a flurry of AI announcements and investor attention around Broadcom ahead of its upcoming earnings, the stock has pulled back sharply from its June peak. The 90 day share price return is 22.86% and the 30 day share price return is 5.03%, as momentum...

Adobe (NasdaqGS:ADBE) is being integrated directly into Dash Social, bringing Adobe Express tools into the social media management platform. The integration lets marketing and social teams move from brand intelligence insights to content creation within a single workflow. The partnership links predictive analytics with creative execution in real time for social media campaigns. The move broadens the application of Adobe Express among marketing users and enterprise clients that rely on Dash...

National Health Investors stock snapshot after recent performance National Health Investors (NHI) has drawn investor attention after a mixed stretch in its share price, with a gain of about 1.6% over the past day contrasting with weaker recent month and year to date returns. At around US$72.27, National Health Investors has seen short term share price momentum fade, with the 30 day share price return down 5.71% and the year to date share price return down 5.96%. However, the 3 year total...

Thermo Fisher Scientific stock has delivered a strong 23.6% gain over the past year, yet current checks suggest the shares now trade close to an intrinsic value estimate rather than at a clear discount. With market multiples also looking roughly in line, the question for you is whether recent gains already reflect much of the company’s long term cash flow potential. The share price return of 23.6% over the past year points to solid recent performance that could limit how much more upside is...

Ameriprise Financial stock triggered by renewed analyst focus Recent analyst commentary on Ameriprise Financial (AMP) has focused on earnings per share growth linked to share buybacks, a strong return on equity, and indications that the stock may be trading below some intrinsic value estimates. Ameriprise Financial’s share price has eased over the past week and month, with a 7 day share price return of 3.15% lower and a 30 day share price return of 0.59% lower. This follows a 90 day share...

Blue Owl Capital Inc. recently announced a total dividend of US$0.31 per share, with an ex-dividend date of 30 September 2026, while co-CEO Doug Ostrover previously presented at Barclays’ 24th Annual Global Financial Services Conference, highlighting the firm’s role as a large alternative asset manager with US$319.00 billion in assets under management as of 30 June 2026. Investor attention is now centered on whether Blue Owl can maintain its quarterly dividend profile given a payout ratio...

The Mosaic Company has redeemed all outstanding US$304,897,000 of its 4.050% Senior Notes due 2027, US$124,122,000 of its 5.375% Senior Notes due 2028, and US$108,211,000 of 7.30% Debentures due 2028 using cash on hand, while also maintaining its regular quarterly dividend of US$0.22 per share announced for payment on September 24, 2026. This early retirement of debt, coupled with an ongoing dividend payout, highlights a shift in Mosaic’s capital structure that could influence its future...

Customer growth and investment plans move into focus Essential Utilities (WTRG) is drawing attention after outlining plans to expand its customer base through organic growth and acquisitions, alongside a planned US$1.7b capital investment program in 2026. Over the past year, Essential Utilities has seen its share price build steady momentum, with a 90 day share price return of 11.11% and a year to date share price return of 6.31%. The 1 year total shareholder return of 9.77% points to...

The Morning Bull - US Market Morning Update Wednesday, Sep, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.5% and Nasdaq-100 futures off nearly 0.9%. The main pressure is coming from a jump in global government bond yields, as UK and European 10-year bonds move to multi year highs and the main German government bond trades above 3.3%. Higher yields mean borrowing costs stay tough for households and companies. At the same time, manufacturing...

Recently, Monolithic Power Systems reported strong momentum in power management solutions tied to AI infrastructure, cloud computing, and networking, supported by a growing pipeline of AI server, optical module, and data center design wins. The company’s ongoing expansion into AI-focused power solutions and broader industrial and automotive applications underlines how power management chips are becoming central to the AI hardware ecosystem. We’ll now examine how this AI-driven demand for...

Oil near $95 to $97, rising bond yields and a sharp risk off mood have put global markets on edge, yet they have also pushed integrated energy and refining stocks into the spotlight. These companies sit at the crossroads of crude prices, fuel demand and dividend income, so their moves can matter for any portfolio. This article walks through 3 stocks from our Global Integrated Energy & Refining Leaders screener that appear positively exposed to the latest Middle East shock, and explains how...

Recent Share Performance and Business Scale Mohawk Industries (MHK) has drawn attention after recent share price moves, with the stock last closing at US$125.04. Investors are weighing this level against the company’s current size and operating footprint. The company reports annual revenue of US$11.18b and net income of US$464.1m, supported by operations across three flooring segments in the United States and international markets. Reported annual revenue and net income growth figures provide...

Tariff refunds worth over $132b are stuck in limbo, and that kind of uncertainty can be a real stress test for small and mid sized businesses that rely on imports. When working capital gets squeezed, lenders that understand this pressure can move from background players to the center of the story. This article walks through three stocks exposed to this refund saga and explains why they may matter for your watchlist right now. The three stocks below are just a sample pulled from a much larger...

Conference appearance puts Morgan Stanley stock back in focus Morgan Stanley (MS) is drawing fresh investor attention ahead of its participation in the ABN AMRO Bank, FIG Capital and Investor Engagement Conference scheduled for August 27, 2026. At a share price of $211.04, Morgan Stanley has seen short-term share price momentum soften, with the 7-day share price return down 2.64%, even as the year-to-date share price return of 16.02% and 1-year total shareholder return of 44.99% reflect...

On 31 August 2026, Ascendis Pharma A/S announced a binding global settlement and license agreement with BioMarin Pharmaceutical, granting Ascendis a non-exclusive, worldwide, royalty-bearing license to continue developing and commercializing navepegritide-related products, while both companies agreed to dismiss all related legal proceedings and BioMarin waived certain regulatory rights and exclusivities. Under this deal, BioMarin stands to receive meaningful royalties on YUVIWEL and other...

In its past Q2 report, Bruker posted revenues of US$838.5 million, a 5.2% year-on-year increase that still came in 1.9% below analyst estimates, and it updated full-year revenue guidance slightly under consensus expectations. This combination of modest growth and softer guidance stood out because peers in the research tools and consumables subsector generally exceeded forecasts, highlighting company-specific execution and demand challenges. Next, we’ll examine how Bruker’s revenue miss...